We serve Chemical Name:6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde CAS:728864-61-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde
CAS.NO:728864-61-7
Synonyms:6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde
Molecular Formula:C9H7ClN2O
Molecular Weight:194.61800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.37g/cm3
Index of Refraction:1.642
PSA:34.37000
Exact Mass:194.02500
LogP:2.10860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde Use and application,6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde technical grade,usp/ep/jp grade.
Related News: This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde manufacturer This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde supplier This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde vendor With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde factory The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.